Concert Pharmaceuticals to Present at the UBS Global Healthcare Conference
12 Mayo 2015 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will present a corporate overview at the UBS Global
Healthcare Conference on Tuesday, May 19, 2015 at 11:30 a.m. ET at
the Sheraton New York Times Square Hotel.
A live webcast of Concert’s presentation may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the webcast will be available on Concert’s website for 2
weeks following the presentation.
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company focused on applying its DCE Platform® (deuterated chemical
entity platform) to create novel small molecule drugs. This
approach starts with approved drugs, advanced clinical candidates
or previously studied compounds that have the potential to be
improved with deuterium substitution to enhance clinical safety,
tolerability and efficacy. The Company is developing a broad
pipeline targeting CNS disorders, genetic diseases, renal disease,
inflammatory diseases and cancer. For more information, please
visit www.concertpharma.com.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
For additional information contact:Concert
Pharmaceuticals, Inc.Justine E. Koenigsberg, 781-674-5284Vice
President, Corporate Communications and Investor
Relationsir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. (MM) Artículos de Noticias